5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Immunogenicity of PRO-169 in Patients With Diabetic Macular EdemaAnti-drug Antibodies (ADAs); ImmunogenicityNot yet recruitingPhase 12026-03-13NCT07429474
PRO-232 in Patients Subjected to Cataract SurgeryCataract ExtractionRecruitingPhase 32025-12-26NCT07305987
Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elongation in Children.Myopia, Progressive, degenerative myopia, eye disorder, myopia, refractive errorRecruitingPhase 32025-03-21NCT06389110
Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.dry eye syndrome, eye disorder, lacrimal apparatus disorderNot yet recruitingPhase 12025-03-19NCT06379685
Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®dry eye syndrome, eye disorder, lacrimal apparatus disorderNot yet recruitingPhase 12025-03-19NCT06375343